ACTH 1-17 and pituitary-adrenal function in human

Francesco Cavagnini; Roldano Fossati

doi:10.1007/BF02904968

ACTH 1-17 and pituitary-adrenal function in human

Francesco Cavagnini, Roldano Fossati

Fondazione Istituto Auxologico Italiano

Research output: Contribution to journal › Article › peer-review

Abstract

In this study we have compared the effects of the ACTH 1-17 analogue, alsactide (Synchrodyn^® 1-17,) and of the ACTH 1-24 fragment, on the dynamics of ACTH-cortisol secretion. In 2 healthy women, 100 μg alsactide injected i.m. at 07⁰⁰ caused a much greater and sustained cortisol secretion than 100 μg ACTH 1-24. However, adrenocortical stimulation effected by alsactide terminated within 24 h, since plasma cortisol levels recorded 24 h after alsactide injection were even lower than the corresponding values of the previous day. In 8 other women, daily administration of 100 μg alsactide at 07⁰⁰ for 15-days resulted in a significant blunting (p

Original language	English
Pages (from-to)	159-165
Number of pages	7
Journal	La Ricerca in Clinica e in Laboratorio
Volume	14
Issue number	2
DOIs	https://doi.org/10.1007/BF02904968
Publication status	Published - Apr 1984

Keywords

ACTH 1-17
ACTH 1-24
ACTH analogues
ACTH-related peptides
Alsactide
Hypothalamo-pituilary-adrenal axis

ASJC Scopus subject areas

Clinical Biochemistry

Access to Document

10.1007/BF02904968

Fingerprint Dive into the research topics of 'ACTH 1-17 and pituitary-adrenal function in human'. Together they form a unique fingerprint.

Cite this

@article{61b5dab7d98748bfa5bcbf24e7411fca,

title = "ACTH 1-17 and pituitary-adrenal function in human",

abstract = "In this study we have compared the effects of the ACTH 1-17 analogue, alsactide (Synchrodyn{\textregistered} 1-17,) and of the ACTH 1-24 fragment, on the dynamics of ACTH-cortisol secretion. In 2 healthy women, 100 μg alsactide injected i.m. at 0700 caused a much greater and sustained cortisol secretion than 100 μg ACTH 1-24. However, adrenocortical stimulation effected by alsactide terminated within 24 h, since plasma cortisol levels recorded 24 h after alsactide injection were even lower than the corresponding values of the previous day. In 8 other women, daily administration of 100 μg alsactide at 0700 for 15-days resulted in a significant blunting (p",

keywords = "ACTH 1-17, ACTH 1-24, ACTH analogues, ACTH-related peptides, Alsactide, Hypothalamo-pituilary-adrenal axis",

author = "Francesco Cavagnini and Roldano Fossati",

year = "1984",

month = apr,

doi = "10.1007/BF02904968",

language = "English",

volume = "14",

pages = "159--165",

journal = "Ricerca in Clinica e in Laboratorio",

issn = "0940-5437",

publisher = "Springer Verlag",

number = "2",

}

TY - JOUR

T1 - ACTH 1-17 and pituitary-adrenal function in human

AU - Cavagnini, Francesco

AU - Fossati, Roldano

PY - 1984/4

Y1 - 1984/4

N2 - In this study we have compared the effects of the ACTH 1-17 analogue, alsactide (Synchrodyn® 1-17,) and of the ACTH 1-24 fragment, on the dynamics of ACTH-cortisol secretion. In 2 healthy women, 100 μg alsactide injected i.m. at 0700 caused a much greater and sustained cortisol secretion than 100 μg ACTH 1-24. However, adrenocortical stimulation effected by alsactide terminated within 24 h, since plasma cortisol levels recorded 24 h after alsactide injection were even lower than the corresponding values of the previous day. In 8 other women, daily administration of 100 μg alsactide at 0700 for 15-days resulted in a significant blunting (p

AB - In this study we have compared the effects of the ACTH 1-17 analogue, alsactide (Synchrodyn® 1-17,) and of the ACTH 1-24 fragment, on the dynamics of ACTH-cortisol secretion. In 2 healthy women, 100 μg alsactide injected i.m. at 0700 caused a much greater and sustained cortisol secretion than 100 μg ACTH 1-24. However, adrenocortical stimulation effected by alsactide terminated within 24 h, since plasma cortisol levels recorded 24 h after alsactide injection were even lower than the corresponding values of the previous day. In 8 other women, daily administration of 100 μg alsactide at 0700 for 15-days resulted in a significant blunting (p

KW - ACTH 1-17

KW - ACTH 1-24

KW - ACTH analogues

KW - ACTH-related peptides

KW - Alsactide

KW - Hypothalamo-pituilary-adrenal axis

UR - http://www.scopus.com/inward/record.url?scp=0021127367&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021127367&partnerID=8YFLogxK

U2 - 10.1007/BF02904968

DO - 10.1007/BF02904968

M3 - Article

C2 - 6091239

AN - SCOPUS:0021127367

VL - 14

SP - 159

EP - 165

JO - Ricerca in Clinica e in Laboratorio

JF - Ricerca in Clinica e in Laboratorio

SN - 0940-5437

IS - 2

ER -